Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancuronium bromide.

M F Roizen, T W Feeley

    Annals of Internal Medicine
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Pancuronium bromide, a muscle relaxant, offers significant benefits for patients needing mechanical ventilation, especially those with specific medical conditions. Careful use is advised to mitigate psychological and physiological risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Management of prediabetes through lifestyle modification in overweight and obese African-American women: the Fitness, Relaxation, and Eating to Stay Healthy (FRESH) randomized controlled trial.

    Public health·2014
    Same author

    Anaesthesia and medical disease.

    Current opinion in anaesthesiology·2006
    Same author

    Monitoring ventilator weaning--predictors of success.

    Journal of clinical monitoring and computing·2003
    Same author

    Characteristics of cardiac arrest in cancer patients as a predictor of survival after cardiopulmonary resuscitation.

    Cancer·2001
    Same author

    Does functional ability in the postoperative period differ between remifentanil- and fentanyl-based anesthesia?

    Journal of clinical anesthesia·2001
    Same author

    Lactate versus chloride: which is better?

    Anesthesia and analgesia·2001
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Anesthesiology
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Pancuronium bromide is a nondepolarizing neuromuscular blocking agent.
    • It is approved for inducing skeletal muscle relaxation during anesthesia.
    • It also aids in managing patients requiring mechanical ventilation.

    Purpose of the Study:

    • To highlight the advantages of pancuronium bromide over previously used muscle relaxants.
    • To identify specific patient populations who benefit from pancuronium bromide.
    • To outline the risks associated with pancuronium bromide use.

    Main Methods:

    • Clinical observations during surgical procedures.
    • Review of patient cases where pancuronium bromide was administered.
    • Identification of contraindications and specific indications for use.

    Related Experiment Videos

    Main Results:

    • Pancuronium bromide is valuable in hypoxemic patients resisting ventilation, those with refractory bronchospasm, severe tetanus or poisoning, status epilepticus, shivering patients, and cases where succinylcholine is contraindicated.
    • Its use facilitates mechanical ventilation and reduces metabolic oxygen demands.
    • Psychological risks, undetected ventilator disconnection, tachyarrhythmias, prolonged paralysis, and drug interactions are potential adverse effects.

    Conclusions:

    • Pancuronium bromide presents distinct advantages in specific critical care and surgical scenarios.
    • Its administration requires careful consideration of patient condition and potential risks.
    • Concomitant sedation is often necessary to mitigate psychological risks.